Development of novel drug delivery systems for targeted therapy in cancer treatment

Thesis Abstract

Abstract
The field of cancer treatment has witnessed significant advancements over the years, with researchers continually exploring novel approaches to improve therapeutic outcomes and minimize adverse effects. One promising avenue is the development of targeted drug delivery systems that can deliver therapeutic agents specifically to cancer cells while sparing healthy tissues. This thesis focuses on the development of such innovative drug delivery systems for targeted therapy in cancer treatment. The introduction sets the stage by highlighting the challenges associated with current cancer treatments, such as systemic toxicity and drug resistance. The background of the study provides a comprehensive overview of drug delivery systems, highlighting the potential benefits of targeted therapy in cancer treatment. The problem statement underscores the need for more effective and less toxic treatment options for cancer patients. The objectives of the study are to design and optimize novel drug delivery systems capable of targeting cancer cells with high precision, evaluate their efficacy in preclinical models, and assess their potential for clinical translation. The limitations of the study are acknowledged, including the complexity of cancer biology and the challenges in translating preclinical findings to clinical settings. The scope of the study encompasses the design and characterization of targeted drug delivery systems, in vitro and in vivo evaluation of their efficacy, and potential strategies for clinical translation. The significance of the study lies in the potential to revolutionize cancer treatment by improving therapeutic outcomes, reducing side effects, and overcoming drug resistance. The structure of the thesis outlines the organization of the subsequent chapters, including a detailed literature review on existing drug delivery systems for cancer treatment, research methodology for designing and evaluating novel systems, discussion of findings from preclinical studies, and a conclusion summarizing the key insights and implications of the research. In the literature review chapter, ten key aspects of existing drug delivery systems for cancer treatment are critically analyzed, highlighting their strengths, limitations, and potential for improvement. The research methodology chapter details the experimental approaches, materials, and techniques used in designing and evaluating novel drug delivery systems, including in vitro and in vivo studies. The discussion of findings chapter presents a thorough analysis of the results obtained from preclinical studies, discussing the efficacy, specificity, and safety profiles of the developed drug delivery systems. The conclusion chapter summarizes the key findings, implications, and future directions of the research, emphasizing the potential impact of targeted drug delivery systems on cancer treatment. In conclusion, the development of novel drug delivery systems for targeted therapy in cancer treatment holds great promise for improving patient outcomes and revolutionizing cancer care. This thesis contributes to the growing body of knowledge in this field and provides a foundation for further research and clinical translation of innovative targeted therapies for cancer.